Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Lipoprotein(a) levels at birth and in early childhood: The COMPARE Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  3. A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: To determine the association between levels of low density lipoprotein cholesterol (LDL-C) and all cause mortality, and the concentration of LDL-C associated with the lowest risk of all cause mortality in the general population.

DESIGN: Prospective cohort study.

SETTING: Denmark; the Copenhagen General Population Study recruited in 2003-15 with a median follow-up of 9.4 years.

PARTICIPANTS: Individuals randomly selected from the national Danish Civil Registration System.

MAIN OUTCOME MEASURES: Baseline levels of LDL-C associated with risk of mortality were evaluated on a continuous scale (restricted cubic splines) and by a priori defined centile categories with Cox proportional hazards regression models. Main outcome was all cause mortality. Secondary outcomes were cause specific mortality (cardiovascular, cancer, and other mortality).

RESULTS: Among 108 243 individuals aged 20-100, 11 376 (10.5%) died during the study, at a median age of 81. The association between levels of LDL-C and the risk of all cause mortality was U shaped, with low and high levels associated with an increased risk of all cause mortality. Compared with individuals with concentrations of LDL-C of 3.4-3.9 mmol/L (132-154 mg/dL; 61st-80th centiles), the multivariable adjusted hazard ratio for all cause mortality was 1.25 (95% confidence interval 1.15 to 1.36) for individuals with LDL-C concentrations of less than 1.8 mmol/L (<70 mg/dL; 1st-5th centiles) and 1.15 (1.05 to 1.27) for LDL-C concentrations of more than 4.8 mmol/L (>189 mg/dL; 96th-100th centiles). The concentration of LDL-C associated with the lowest risk of all cause mortality was 3.6 mmol/L (140 mg/dL) in the overall population and in individuals not receiving lipid lowering treatment, compared with 2.3 mmol/L (89 mg/dL) in individuals receiving lipid lowering treatment. Similar results were seen in men and women, across age groups, and for cancer and other mortality, but not for cardiovascular mortality. Any increase in LDL-C levels was associated with an increased risk of myocardial infarction.

CONCLUSIONS: In the general population, low and high levels of LDL-C were associated with an increased risk of all cause mortality, and the lowest risk of all cause mortality was found at an LDL-C concentration of 3.6 mmol/L (140 mg/dL).

Original languageEnglish
Article numberm4266
JournalBMJ
Volume371
Pages (from-to)m4266
ISSN1756-1833
DOIs
Publication statusPublished - 8 Dec 2020

    Research areas

  • Adult, Aged, Aged, 80 and over, Cardiovascular Diseases/blood, Cause of Death, Cholesterol, LDL/blood, Denmark/epidemiology, Female, Humans, Male, Middle Aged, Mortality/trends, Neoplasms/blood, Proportional Hazards Models, Prospective Studies, Registries, Risk Factors

ID: 61899202